Total raised
$14.5M
Last: Series B 2012-02
Stage
Series B
Founded
2003
Headcount
10
HQ
Haifa
Sector
Health Tech & Life Sciences
About
CorAssist is a clinical-stage medical device company developing therapeutic products for treating heart failure with preserved ejection fraction. The companys proprietary technology enables the implantation of a device that directly improves cardiac diastolic function. CORolla is an elastic, self-expanding, internal, spring-like device implanted inside the left ventricle through a transapical or percutaneous procedure. The device assists diastolic function by improving diastolic dynamics and filling performance, and does not require an external power source. ImCardia, the companys first product, is an elastic, self-expanding device that is attached to the external left ventricular surface through a simple off-pump procedure.
Funding history · 4 rounds · $14.5M total
2012-02
Series B
$4.8M
2009-03
Series A
$5.2M
2006-01
Seed
$4.0M
2004-07
Pre-Seed
$500K
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B
Tags
minimally-invasivecardiologymedical-devicestherapeuticsheart-failuresurgerychronic-patientscardiovascularhospitalshealthcare-providersclinics